SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
RDE, Inc. (RSTN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RSTN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.35
Book Value / Share$0.00
Revenue / Share$2,787.06
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2005 |
$-1,630.24 |
$32.28K |
$-11.19M |
-34668.6% |
| 2016 |
$-1.78 |
$0.00 |
$-117.62K |
- |
| 2017 |
$-11.67 |
$7K |
$-1.33M |
-19000% |
| 2018 |
$-0.44 |
$567K |
$-677K |
-119.4% |
| 2019 |
$-5.15 |
$4.14M |
$-15.35M |
-370.3% |
| 2020 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2022 |
$-0.10 |
$4.44M |
$-1.39M |
-31.3% |
| 2023 |
$-0.01 |
$87.15M |
$-124.55K |
-0.1% |
| 2024 |
$-0.73 |
$88.93B |
$-18.83B |
-21.2% |
| 2025 |
$-0.35 |
$83.18B |
$-10.49B |
-12.6% |
